Qatar Biobank is set to host the Second Qatar Biobanking Congress, focusing on precision medicine initiatives in Qatar and around the world as part of its mission to bring personalized healthcare to the country.
Under the overarching theme, ‘The Impact of Biobanking on Precision Medicine Initiatives’, the conference will be held from March 14 - 15 at Qatar National Convention Centre (QNCC).
The two-day event will feature an international group of experts on biobanking, genomics and personalized medicine from around the world, with a focus on using precision medicine to improve clinical outcomes. Sidra Medical and Research Center (Sidra) and Hamad Medical Corporation (HMC) are co-organizers of the congress.
Dr. Asma Al Thani, Chair of Qatar Genome Programme Committee and Board Vice Chairperson of Qatar Biobank, said: “By bringing together leading researchers, policy-makers and healthcare providers, the Second Qatar Biobanking Congress will advance the discussion of precision medicine around the world, and enable valuable knowledge sharing so that attendees may advance the efficiency and value of healthcare in their own countries.”
The conference welcomes medical practitioners, health and genomic researchers, biobanking experts and the public to take part in planned debates. The wide-ranging sessions and presentations will primarily be themed around a review of precision medicine initiatives in Qatar; ethical and Islamic perspectives on biobanking and genomic research; worldwide trends in precision medicine; and industry case studies from Qatar, the region and worldwide.
All those interested can register through the conference website: http://www.qatarbiobank.org.qa/qbb-conference/
For the full story, please click here